ANDREA BEATTY: Open Payments
NPI 1790201655 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 18 payments from 6 companies in 2025. Trend: 2023 $903 · 2024 $1,617 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $452 |
| Janssen Biotech, Inc. | 2 | $269 |
| GlaxoSmithKline, LLC. | 6 | $192 |
| PFIZER INC. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $98 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: OPDIVO, RYBREVANT, BREYANZI, TIVDAK, ZEJULA, LYNPARZA, JEMPERLI, YERVOY.
Industry payments across CA — which companies pay providers there.
